In gallbladder cancer, miR-335 suppresses the myocyte enhancer factor-2D (MEF2D) and improves cell proliferation as well as increasing the sensitivity of cancer cells to 5-fluorouracil chemotherapy (Ye et al., 2021). Here, MEF2D is linked to cancer.